Becton, Dickinson Wins Designation Allowing European Sales of Coronavirus Test
Earlier this week, Becton, Dickinson (NYSE: BDX) revealed that it has been given a crucial new green light to market its rapid test for the detection of the novel coronavirus. The healthcare technology specialist has been awarded a CE Mark for its SARS-CoV-2 assay, meaning it can be sold throughout Europe in countries that support the quality designation.
According to Becton, Dickinson, its SARS-CoV-2 antibody test produces results in 15 minutes. It is processed using the BD Veritor Plus System, a handheld and portable device used for various diagnostics that can be administered where the test subject is situated. The device already carries a CE Mark.
Image source: Becton, Dickinson.
Source Fool.com
